Acupuncture in polycystic ovary syndrome: Current experimental and clinical evidence

Journal of Neuroendocrinology

Volumn 20, Issue 3, 2008, Pages 290-298

  Stener Victorin, E ^a   Jedel, E ^b   Manneras L ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Acupuncture; Insulin resistance; Metabolic syndrome; Obesity; Opioids; Ovulation; Physical exercise; Polycystic ovary syndrome; Sympathetic nerve activity

Indexed keywords

PLACEBO; STEROID;

ACUPUNCTURE; ADRENERGIC SYSTEM; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENDOCRINE DISEASE; ENDOCRINE SYSTEM; FEMALE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; MENTAL HEALTH; METABOLIC DISORDER; NEUROENDOCRINE SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYMPATHETIC NERVE; SYMPTOM;

ACUPUNCTURE; ANIMALS; FEMALE; HUMANS; MODELS, ANIMAL; MODELS, BIOLOGICAL; OVULATION; PLACEBO EFFECT; POLYCYSTIC OVARY SYNDROME; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 39549100115     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2007.01634.x     Document Type: Review

References (96)

1. Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 2006; 65: 137-145.
2. Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004; 60: 1-17.
3. Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: A review. Obstet Gynecol Surv 2006; 61: 723-732.
4. Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 2007; 22: 2279-2286.
5. Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol 2006; 11: 613-625.
6. Pinhas-Hamiel O, Pilpel N, Carel C, Singer S. Clinical and laboratory characteristics of adolescents with both polycystic ovary disease and anorexia nervosa. Fertil Steril 2006; 85: 1849-1851.
7. Carmina E, Legro RS, Stamets K, Lowell J, Lobo RA. Difference in body weight between American and Italian women with polycystic ovary syndrome: Influence of the diet. Hum Reprod 2003; 18: 2289-2293.
8. Douglas CC, Norris LE, Oster RA, Darnell BE, Azziz R, Gower BA. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. Fertil Steril 2006; 86: 411-417.
9. Gilling-Smith C, Story H, Rogers V, Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1997; 47: 93-99.
10. Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 2002; 174: 1-5.
11. Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001; 52: 401-419.
12. Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod 2006; 21: 80-89.
13. Hoeger KM. Obesity and lifestyle management in polycystic ovary syndrome. Clin Obstet Gynecol 2007; 50: 277-294.
14. Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002; 13: 251-257.
15. Gambineri A, Patton L, Vaccina A, Cacciari M, Morselli-Labate AM, Cavazza C, Pagotto U, Pasquali R. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: A randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab 2006; 91: 3970-3980.
16. Ibanez L, Ong K, de Zegher F, Marcos MV, del Rio L, Dunger DB. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clin Endocrinol (Oxf) 2003; 58: 372-379.
17. Faulds G, Ryden M, Ek I, Wahrenberg H, Arner P. Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome. J Clin Endocrinol Metab 2003; 88: 2269-2273.
18. Urbanek M. The genetics of the polycystic ovary syndrome. Nat Clin Pract 2007; 3: 103-111.
19. Patel K, Coffler M, Dahan M, Malcom P, Deutsch A, Chang R. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome. Clin Endocrinol 2004; 60: 67-74.
20. Cumming DC, Reid RL, Quigley ME, Rebar RW, Yen SS. Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome. Clin Endocrinol (Oxf) 1984; 20: 643-648.
21. Hayden BJ, Balen AH. The role of the central nervous system in the pathogenesis of polycystic ovary syndrome. Minerva Ginecol 2006; 58: 41-54.
22. Carmina E, Ditkoff EC, Malizia G, Vijod AG, Janni A, Lobo RA. Increased circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion. Am J Obstet Gynecol 1992; 167: 1819-1824.
23. Lobo RA, Granger LR, Paul WL, Goebelsmann U, Mishell DR Jr. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am J Obstet Gynecol 1983; 145: 496-503.
24. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823.
25. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 1994; 23: 570-578.
26. Dahlgren E, Janson PO, Johansson S, Lapidus L, Lindstedt G, Tengborn L. Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril 1994; 61: 455-460.
27. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-861.
28. Grassi G, Seravalle G, Quarti-Trevano F, Scopelliti F, Dell'Oro R, Bolla G, Mancia G. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms. Hypertension 2007; 49: 535-541.
29. Ojeda S, Lara H. Role of the Sympathetic Nervous System in the Regulation of Ovarian Function. Berlin: Springer-Verlag, 1989.
30. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: Possible implications in prenatal androgenization. Hum Reprod 2002; 17: 2573-2579.
31. Fagius J. Sympathetic nerve activity in metabolic control - some basic concepts. Acta Physiol Scand 2003; 177: 337-343.
32. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381.
33. Wu X, Sallinen K, Zhou S, Su Y, Pollanen P, Erkkola R. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome. Fertil Steril 2000; 73: 730-734.
34. Semenova I. Adrenergic innervation of the ovaries in Stein-Leventhal syndrome. Vestn Akad Med Nauk SSSR (Abstract in English). 1969; 24: 58-62.
35. Heider U, Pedal I, Spanel-Borowski K. Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries. Fertil Steril 2001; 75: 1141-1147.
36. Greiner M, Paredes A, Araya V, Lara HE. Role of stress and sympathetic innervation in the development of polycystic ovary syndrome. Endocrine 2005; 28: 319-324.
37. Balen A. Surgical treatment of polycystic ovary syndrome. Best Pract Res 2006; 20: 271-280.
38. Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: A developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 2005; 11: 357-374.
39. Dumesic DA, Abbott DH, Padmanabhan V. Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord. 2007; 8: 127-141.
40. Brawer JR, Munoz M, Farookhi R. Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat. Biol Reprod 1986; 35: 647-655.
41. Barria A, Leyton V, Ojeda SR, Lara HE. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: Role of sympathetic innervation. Endocrinology 1993; 133: 2696-2703.
42. Lara HE, Ferruz JL, Luza S, Bustamante DA, Borges Y, Ojeda SR. Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology 1993; 133: 2690-2695.
43. Lara HE, Dissen GA, Leyton V, Paredes A, Fuenzalida H, Fiedler JL, Ojeda SR. An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. Endocrinology 2000; 141: 1059-1072.
44. Ahmed CE, Dees WL, Ojeda SR. The immature rat ovary is innervated by vasoactive intestinal peptide (VIP)-containing fibers and responds to VIP with steroid secretion. Endocrinology 1986; 118: 1682-1689.
45. Stener-Victorin E, Lundeberg T, Waldenstrom U, Manni L, Aloe L, Gunnarsson S, Janson PO. Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries. Biol Reprod 2000; 63: 1497-1503.
46. Stener-Victorin E, Lundeberg T, Cajander S, Aloe L, Manni L, Waldenstrom U, Janson PO. Steroid-induced polycystic ovaries in rats: Effect of electro-acupuncture on concentrations of endothelin-1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system. Reprod Biol Endocrinol 2003; 1: 33.
47. Manni L, Holmang A, Lundeberg T, Aloe L, Stener-Victorin E. Ovarian expression of alpha (1)- and beta (2)-adrenoceptors and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries. Auton Neurosci 2005; 118: 79-87.
48. Stener-Victorin E, Ploj K, Larsson BM, Holmang A. Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity. Reprod Biol Endocrinol 2005; 3: 44.
49. Beloosesky R, Gold R, Almog B, Sasson R, Dantes A, Land-Bracha A, Hirsh L, Itskovitz-Eldor J, Lessing JB, Homburg R, Amsterdam A. Induction of polycystic ovary by testosterone in immature female rats: Modulation of apoptosis and attenuation of glucose/insulin ratio. Int J Mol Med 2004; 14: 207-215.
50. Kafali H, Iriadam M, Ozardali I, Demir N. Letrozole-induced polycystic ovaries in the rat: A new model for cystic ovarian disease. Arch Med Res 2004; 35: 103-108.
51. Mannerås L, Cajander S, Holmäng A, Seleskovic Z, Lystig T, Lönn M, Stener-Victorin E. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 2007; 148: 3781-3791.
52. Lanham MS, Lebovic DI, Domino SE. Contemporary medical therapy for polycystic ovary syndrome. Int J Gynaecol Obstet 2006; 95: 236-241.
53. Kagitani F, Uchida S, Hotta H, Aikawa Y. Manual acupuncture needle stimulation of the rat hindlimb activates groups I, II, III and IV single afferent nerve fibers in the dorsal spinal roots. Jpn J Physiol 2005; 55: 149-155.
54. Kaufman MP, Waldrop TG, Rybycki KJ, Ordway GA, Mitchell JH. Effects of static and rythmic twitch contractions on the discharge of group III and IV muscle afferents. Cardiovasc Res 1984; 18: 663-668.
55. Andersson S, Lundeberg T. Acupuncture-from empiricism to science: functional background to acupuncture effects in pain and disease. Med Hypotheses 1995; 45: 271-281.
56. Basbaum AI, Fields HL. Endogenous pain control systems: Brain-stem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984; 7: 309-338.
57. Crine P, Gianoulakis C, Seidah NG. Biosynthesis of beta-endorphin from beta-lipotropin and a larger molecular weight precursor in rat pars intermedia. Proc Natl Acad Sci U S A 1978; 75: 4719-4723.
58. Rivier C, Rivest S. Effects of stress on the activity of hypothalamic-pituitary-gonadal axis: Peripheral and central mechanisms. Biol Reprod 1991; 45: 523-532.
59. Harbach H, Moll B, Boedeker RH, Vigelius-Rauch U, Otto H, Muehling J, Hempelmann G, Markart P. Minimal immunoreactive plasma beta-endorphin and decrease of cortisol at standard analgesia or different acupuncture techniques. Eur J Anaesthesiol 2007; 24: 370-376.
60. Chen BY. Acupuncture normalizes dysfunction of hypothalamic-pituitary-ovarian axis. Acupunct Electrother Res 1997; 22: 97-108.
61. Stener-Victorin E, Lundeberg T, Waldenstrom U, Bileviciute-Ljungar I, Janson PO. Effects of electro-acupuncture on corticotropin-releasing factor in rats with experimentally-induced polycystic ovaries. Neuropeptides 2001; 35: 227-231.
62. Stener-Victorin E, Waldenstrom U, Tagnfors U, Lundeberg T, Lindstedt G, Janson PO. Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2000; 79: 180-188.
63. Stener-Victorin E, Lindholm C. Immunity and beta-endorphin concentrations in hypothalamus and plasma in rats with steroid-induced polycystic ovaries: Effect of low-frequency electroacupuncture. Biol Reprod 2004; 70: 329-333.
64. Sato A, Sato Y, Schmidt RF. The Impact of Somatosensory Input on Autonomic Functions. Heidelberg: Springer-Verlag, 1997.
65. Stener-Victorin E, Kobayashi R, Kurosawa M. Ovarian blood flow responses to electro-acupuncture stimulation at different frequencies and intensities in anaesthetized rats. Auton Neurosci 2003; 108: 50-56.
66. Stener-Victorin E, Fujisawa S, Kurosawa M. Ovarian blood flow responses to electroacupuncture stimulation depend on estrous cycle and on site and frequency of stimulation in anesthetized rats. J Appl Physiol 2006; 101: 84-91.
67. Fulghesu AM, Ciampelli M, Guido M, Murgia F, Caruso A, Mancuso S, Lanzone A. Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease. Metabolism 1998; 47: 158-162.
68. Lanzone A, Fulghesu AM, Cucinelli F, Ciampelli M, Caruso A, Mancuso S. Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: Relationship with insulin and luteinizing hormone secretion. J Clin Endocrinol Metab 1995; 80: 3501-3506.
69. Ciampelli M, Fulghesu AM, Guido M, Murgia F, Muzj G, Belosi C, Fortini A, Cento R, Lanzone A. Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus. Horm res 1998; 49: 263-268.
70. Stener-Victorin E, Wikland M, Waldenstrom U, Lundeberg T. Alternative treatments in reproductive medicine: Much ado about nothing: Acupuncture-a method of treatment in reproductive medicine: Lack of evidence of an effect does not equal evidence of the lack of an effect. Hum Reprod 2002; 17: 1942-1946.
71. Kim SK, Lee G, Shin M, Han JB, Moon HJ, Park JH, Kim KJ, Ha J, Park DS, Min BI. The association of serum leptin with the reduction of food intake and body weight during electroacupuncture in rats. Pharmacol Biochem Behav 2006; 83: 145-149.
72. Lee M, Kim J, Lim H-J, Shin B-S. Effects of abdominal electroacupuncture on parameters related to obesity in obese women: A pilot study. Complement Ther Clin Pract 2006; 12: 97-100.
73. Cabioglu MT, Ergene N. Electroacupuncture therapy for weight loss reduces serum total cholesterol, triglycerides, and LDL cholesterol levels in obese women. Am J Chin Med 2005; 33: 525-533.
74. Cabioglu MT, Ergene N. Changes in levels of serum insulin, C-Peptide and glucose after electroacupuncture and diet therapy in obese women. Am J Chin Med 2006; 34: 367-376.
75. Cabioglu MT, Ergene N. Changes in serum leptin and beta endorphin levels with weight loss by electroacupuncture and diet restriction in obesity treatment. Am J Chin Med 2006; 34: 1-11.
76. Holmang A, Mimura K, Lonnroth P. Involuntary leg movements affect interstitial nutrient gradients and blood flow in rat skeletal muscle. J Appl Physiol 2002; 92: 982-988.
77. Chang SL, Tsai CC, Lin JG, Hsieh CL, Lin RT, Cheng JT. Involvement of serotonin in the hypoglycemic response to 2Hz electroacupuncture of zusanli acupoint (ST36) in rats. Neurosci Lett 2005; 379: 69-73.
78. Chang S-L, Lin K-J, Lin R-T, Hung P-H, Lin J-G, Cheng J-T. Enhanced insulin sensitivity using electroacupuncture on bilateral Zusanli acupoints (ST 36) in rats. Life Sci 2006; 79: 967-971.
79. Xiaoming MO, Ding LI, Yunxing PU, Guifang XI, Xiuzhen LE, Zhimin FU. Clinical studies on the mechanism for acupuncture stimulation of ovulation. J Tradit Chin Med 1993; 13: 115-119.
80. Chen BY, Yu J. Relationship between blood radioimmunoreactive beta-endorphin and hand skin temperature during the electro-acupuncture induction of ovulation. Acupunct Electrother Res 1991; 16: 1-5.
81. Cai X. Substitution of acupuncture for HCG in ovulation induction. J Tradit Chin Med 1997; 17: 119-121.
82. Gerhard I, Postneek F. Auricular acupuncture in the treatment of female infertility. Gynecol Endocrinol 1992; 6: 171-181.
83. Manni L, Holmang A, Cajander S, Lundeberg T, Aloe L, Stener-Victorin E. Effect of anti-NGF on the ovarian expression of {alpha}1- and {beta}2-adrenoceptors, TrkA, p75NTR, and tyrosine hydroxylase in rats with steroid-induced polycystic ovaries. Am J Physiol Regul Integr Comp Physiol 2005; 290: R826-R835.
84. Stener-Victorin E, Kobayashi R, Watanabe O, Lundeberg T, Kurosawa M. Effect of electro-acupuncture stimulation of different frequencies and intensities on ovarian blood flow in anaesthetised rats with steroid-induced polycystic ovaries. Reprod Biol Endocrinol 2004; 2: 16.
85. Manni L, Cajander S, Lundeberg T, Naylor AS, Aloe L, Holmang A, Jonsdottir IH, Stener-Victorin E. Effect of exercise on ovarian morphology and expression of nerve growth factor and alpha(1)- and beta(2)-adrenergic receptors in rats with steroid-induced polycystic ovaries. J Neuroendocrinol 2005; 17: 846-858.
86. Manni L, Lundeberg T, Holmang A, Aloe L, Stener-Victorin E. Effect of electro-acupuncture on ovarian expression of alpha (1)- and beta (2)-adrenoceptors, and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries. Reprod Biol Endocrinol 2005; 3: 21.
87. Smith C, Hay P. Acupuncture for depression (Review). The Cochrane Library 2005; 1-21.
88. Gallagher SM, Allen JJ, Hitt SK, Schnyer RN, Manber R. Six-month depression relapse rates among women treated with acupuncture. Complement Ther Med 2001; 9: 216-218.
89. Streitberger K, Kleinhenz J. Introducing a placebo needle into acupuncture research. Lancet 1998; 352: 364-365.
90. White P, Lewith G, Hopwood V, Prescott P. The placebo needle, is it a valid and convincing placebo for use in acupuncture trials? A randomised, single-blind, cross-over pilot trial. Pain 2003; 106: 401-409.
91. Olausson H, Lamarre Y, Backlund H, Morin C, Wallin BG, Starck G, Ekholm S, Strigo I, Worsley K, Vallbo AB, Bushnell MC. Unmyelinated tactile afferents signal touch and project to insular cortex. Nat Neurosci 2002; 5: 900-904.
92. Lund I, Lundeberg T. Are minimal, superficial or sham acupuncture procedures acceptable as inert placebo controls? Acupunct Med 2006; 24: 13-15.
93. Linde K, Streng A, Jurgens S, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, Pfaffenrath V, Hammes MG, Weidenhammer W, Willich SN, Melchart D. Acupuncture for patients with migraine: A randomized controlled trial. JAMA 2005; 293: 2118-2125.
94. Moher D, Schulz KF, Altman D. The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore (NY) 2005; 1: 40-45.
95. MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R. Standards for reporting interventions in controlled trials of acupuncture: The STRICTA recommendations. Complement Ther Med 2001; 9: 246-249.
96. Vincent C. The safety of acupuncture. BMJ 2001; 323: 467-468.